NCT03704207

Utility of PCD Diagnostics to Improve Clinical Care

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Vanderbilt University Medical Center · Academic / Other
• Sex: All
• Age: 1 Year
• Healthy volunteers: Not accepted

Summary

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.

Detailed description

This study is a prospective data collection of individuals referred to the investigators clinical center for considerations of PCD. Participants sign informed consent to have clinical information entered into a secure electronic database. As part of this study, participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research procedure, but it is a test with growing utility for making a diagnosis of PCD when performed in the right clinical setting.

Conditions

• Primary Ciliary Dyskinesia

Interventions

Type	Name	Description
OTHER	nNO testing	Collection of already performed clinical data and nNO testing

Timeline

• Start date: 2017-06-01
• Primary completion: 2028-06-01
• Completion: 2028-06-01
• First posted: 2018-10-12
• Last updated: 2025-07-01

Locations

1 site across 1 country: United States